Toth Financial Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Hold
0
-$21.7K 751
2024
Q1
Hold
0
380
2023
Q4
Hold
0
525
2022
Q4
Hold
0
-$7K 724
2022
Q3
Hold
0
509
2022
Q2
Sell
-100
Closed -$7.62K 463
2022
Q1
$7K Hold
100
﹤0.01% 506
2021
Q4
$6K Buy
+100
New +$5.87K ﹤0.01% 537

Other funds holding BMY

Toth Financial Advisory's BMY Position: Q2 2026 in Review

Toth Financial Advisory increased its Bristol-Myers Squibb (BMY) stake by 4.3% in Q2 2026, buying an estimated $231K and bringing the position to 97,037 shares worth $5.59M. The position accounts for 0.55% of the portfolio, ranked #65.

Toth Financial Advisory first reported a position in BMY in Q3 2019 and has held it in 28 quarters since. The position peaked at $7.89M in Q2 2022. 624 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Toth Financial Advisory held 97,037 shares of Bristol-Myers Squibb worth $5.59M as of Q2 2026.
  • Toth Financial Advisory bought 4,016 Bristol-Myers Squibb shares in Q2 2026, an estimated $231K.
  • Bristol-Myers Squibb made up 0.55% of Toth Financial Advisory's portfolio in Q2 2026, its #65 holding.
  • Toth Financial Advisory first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 28 quarters since.
  • Toth Financial Advisory's Bristol-Myers Squibb position peaked at $7.89M in Q2 2022.
  • 624 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.